Overview

Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

Purpose: to evaluate the effect of intravitreal injection of tissue plasminogen activator(tPA) in treatment of refractory diabetic macular edema(DME).

Phase:

N/A

Details

Lead Sponsor:

Mashhad University of Medical Sciences

Treatments:

Bevacizumab
Plasminogen
Tissue Plasminogen Activator